Search research articles
Contact Us
Filters
Showing results (261-270 of 281) with videos related to
Page
of 29
Sort By:
Antimicrobial Agents and Chemotherapy
|
June 1, 1990
Phase I study of multiple-dose cefprozil and comparison with cefaclor
R H Barbhaiya, U A Shukla, C R Gleason, et al.
Cancer Research
|
April 1, 1977
Aryl hydrocarbon hydroxylase activity in pulmonary macrophages and lymphocytes from lung cancer and noncancer patients
T L McLemore, R R Martin, D L Busbee, et al.
Antimicrobial Agents and Chemotherapy
|
February 1, 1982
Comparative trial of cefonicid and cefamandole in the therapy of community-acquired pneumonia
R J Wallace, S L Niefield, S Waters, et al.
Clinical Pharmacology and Therapeutics
|
May 1, 1991
Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex
C A Knupp, W C Shyu, R Dolin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 25, 2000
A safety and pharmacokinetic study of a mixed-backbone oligonucleotide (GEM231) targeting the type I protein kinase A by two-hour infusions in patients with refractory solid tumors
H X Chen, J L Marshall, E Ness, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1995
Pharmacokinetics of an anti-human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects
R Zhang, J Yan, H K Shahinian, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1992
Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects
R H Barbhaiya, S T Forgue, C R Gleason, et al.
Reviews of Infectious Diseases
|
May 1, 1987
Social, behavioral, and practical factors affecting antibiotic use worldwide: report of Task Force 4
C M Kunin, H L Lipton, T Tupasi, et al.
Cancer Letters
|
April 1, 1980
Asbestos body phagocytosis by human free alveolar macrophages
T L McLemore, M L Mace, V Roggli, et al.
Journal of Clinical Pharmacology
|
February 13, 1999
Pharmacokinetics and tolerability of intravenous trecovirsen (GEM 91), an antisense phosphorothioate oligonucleotide, in HIV-positive subjects
D Séréni, R Tubiana, C Lascoux, et al.
Page
of 29
Search research articles
Search
Showing results (261-270 of 281) with videos related to
Sort By:
Page
of 29
Antimicrobial Agents and Chemotherapy
|
June 1, 1990
Phase I study of multiple-dose cefprozil and comparison with cefaclor
R H Barbhaiya, U A Shukla, C R Gleason, et al.
Cancer Research
|
April 1, 1977
Aryl hydrocarbon hydroxylase activity in pulmonary macrophages and lymphocytes from lung cancer and noncancer patients
T L McLemore, R R Martin, D L Busbee, et al.
Antimicrobial Agents and Chemotherapy
|
February 1, 1982
Comparative trial of cefonicid and cefamandole in the therapy of community-acquired pneumonia
R J Wallace, S L Niefield, S Waters, et al.
Clinical Pharmacology and Therapeutics
|
May 1, 1991
Pharmacokinetics of didanosine in patients with acquired immunodeficiency syndrome or acquired immunodeficiency syndrome-related complex
C A Knupp, W C Shyu, R Dolin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 25, 2000
A safety and pharmacokinetic study of a mixed-backbone oligonucleotide (GEM231) targeting the type I protein kinase A by two-hour infusions in patients with refractory solid tumors
H X Chen, J L Marshall, E Ness, et al.
Clinical Pharmacology and Therapeutics
|
July 1, 1995
Pharmacokinetics of an anti-human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects
R Zhang, J Yan, H K Shahinian, et al.
Antimicrobial Agents and Chemotherapy
|
March 1, 1992
Pharmacokinetics of cefepime after single and multiple intravenous administrations in healthy subjects
R H Barbhaiya, S T Forgue, C R Gleason, et al.
Reviews of Infectious Diseases
|
May 1, 1987
Social, behavioral, and practical factors affecting antibiotic use worldwide: report of Task Force 4
C M Kunin, H L Lipton, T Tupasi, et al.
Cancer Letters
|
April 1, 1980
Asbestos body phagocytosis by human free alveolar macrophages
T L McLemore, M L Mace, V Roggli, et al.
Journal of Clinical Pharmacology
|
February 13, 1999
Pharmacokinetics and tolerability of intravenous trecovirsen (GEM 91), an antisense phosphorothioate oligonucleotide, in HIV-positive subjects
D Séréni, R Tubiana, C Lascoux, et al.
Page
of 29